🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II trial to determine the ability of a reduced intensity co...
Status
Completed
Location
The Children's Hospital of Philadelphia
Start Date
2011-11
Trial ID
NCT02277639
Treatments Being Tested
This is a single-institution, phase II study to determine the event-free su...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2016-03
Trial ID
NCT02582775
The study is designed as a Phase III, multi-center trial of tandem autologo...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-12
Trial ID
NCT00075829
While cord blood transplants have been performed safely in elderly patients...
Status
Completed
Location
Loyola University Medical Center
Start Date
2010-01
Trial ID
NCT01484470
Treatments Being Tested
Although the survival of children with sickle cell disease (SCD) has dramat...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-15
Trial ID
NCT04046705
Treatments Being Tested
This study will test the combination of clofarabine, cytarabine, and thymog...
Status
Terminated
Location
Ravi Vij, M.D.
Start Date
2007-11
Trial ID
NCT00593645
Treatments Being Tested
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the ...
Status
Recruiting
Location
CHU Amiens
Start Date
2023-11-28
Trial ID
NCT06083129
Treatments Being Tested
The goal of this clinical research study is to learn if adding Zevalin (ibr...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-01
Trial ID
NCT01490723
This is a phase II study to assess the day 180 event free and overall survi...
Status
Terminated
Location
University of Virginia
Start Date
2012-01
Trial ID
NCT01622556
Treatments Being Tested
This study will examine the influence of donor and recipient pharmacogeneti...
Status
Recruiting
Location
Levine Cancer Institute
Start Date
2018-07-13
Trial ID
NCT03555851
Treatments Being Tested